Cipla Global Highlights

-

#2

Ranked in sale of inhalers globally

Source: Cipla Annual Report 2022-23

-

129.10 Million

Aerosol pMDI units produced

-

43.20 Million

Nasal spray units produced

-

726.90 Million

Respule units produced

-

28.34 Billion

Tablets and capsules produced

Overview

Our Products

Contact Information